Berlin - Delayed Quote EUR

Aurinia Pharmaceuticals Inc (IKAP.BE)

Compare
8.59 -0.03 (-0.32%)
At close: December 23 at 8:13:02 AM GMT+1

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

27.3

Medium

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
AURA Aura Biosciences, Inc. 27 -- -- --
A71.SG Ascendis Pharma A/S (ADRs) 27 -- -- --
PMR.DU PMR.DU,0P0001MQ56,0 27 3 18 6
IKAP.BE Aurinia Pharmaceuticals Inc. R 27 -- -- --
7R8.F Replimune Group Inc. R 27 -- -- --

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 12/2024
IKAP.BE
Category Average
1 Low Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No